BME · BlackRock Health Sciences Trust

Know the company

Company overview

BlackRock Health Sciences Trust invests in healthcare companies and looks for investment appreciation alongside income. Option writing stopped being a principal strategy in November 2025, so older option-driven results should not be treated as the same playbook.

Business: Healthcare equity CEF
Listing: BME · XNYS
Reporting period: 2026-06-30
Dividend schedule: Monthly

How the business works

Company dividends add income, but changes in healthcare share values and realized gains are central to this equity fund. NAV and cash paid together tell more than a bond-style income coverage number.

BME financial statements and industry allocation

Current company data

Latest reported earnings per share$0.07Fund net investment income per common share; actual reporting period, not annualized · 2026-01-01 through 2026-06-30

Latest declared dividend$0.2621Monthly; current regular payment checked 2026-09-11

Source dateSeptember 21, 2026Latest available source

Net asset value (NAV)

NAV per share$46.2800Sep 29, 2026

Market price$44.6200Sep 29, 2026

PREMIUM / DISCOUNT TO NAV3.59% discountCalculated from the displayed same-date values.

NAV is the fund's assets minus liabilities, divided by shares outstanding. All values are USD per share.

CEFConnect current common-share NAV and closing market price, both dated 2026-09-29. The published premium or discount agrees with the calculation within source rounding. Older audited NAV history remains unchanged.

NAV source · Market-price source

Return to company research